We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Biogen
BIIB
$29.5B
| $5.01M | 0.01% |
+23,228
| New | +$5.44M |
|
|
EXE
977
Expand Energy Corp
EXE
$21.7B
| $5M | 0.01% |
+56,339
| New | +$4.52M |
|
978
Ironwood Pharmaceuticals
IRWD
$644M
| $4.99M | 0.01% |
572,500
+284,680
| +99% | +$3.45M |
|
979
Lumentum
LITE
$55.4B
| $4.97M | 0.01% |
105,046
+89,557
| +578% | +$4.55M |
|
980
Applied Optoelectronics
AAOI
$7.85B
| $4.97M | 0.01% |
+358,527
| New | +$6.04M |
|
981
Genesco
GCO
$416M
| $4.97M | 0.01% |
176,524
-50,629
| -22% | -$1.46M |
|
982
Credo Technology Group
CRDO
$38.8B
| $4.9M | 0.01% |
231,204
-546,129
| -70% | -$11.4M |
|
983
VTEX
VTEX
$718M
| $4.89M | 0.01% |
598,228
+575,968
| +2,587% | +$4.61M |
|
984
Conagra Brands
CAG
$7.29B
| $4.88M | 0.01% |
164,557
-14,343
| -8% | -$409K |
|
985
Gray Television
GTN
$409M
| $4.86M | 0.01% |
769,588
+274,432
| +55% | +$2.1M |
|
986
Ambev
ABEV
$47.4B
| $4.86M | 0.01% |
+1,959,445
| New | +$5.1M |
|
|
HAIAW
987
CALL
DELISTED
Healthcare AI Acquisition Corp. Warrants
HAIAW
| $4.86M | 0.01% |
436,175
| – | – |
|
988
Simply Good Foods
SMPL
$943M
| $4.85M | 0.01% |
142,454
-32,208
| -18% | -$1.19M |
|
|
PUCKW
989
CALL
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
| $4.85M | 0.01% |
450,000
| – | – |
|
990
IDEAYA Biosciences
IDYA
$3.54B
| $4.84M | 0.01% |
+110,351
| New | +$4.74M |
|
991
UBS Group
UBS
$172B
| $4.82M | 0.01% |
156,423
-1,208,266
| -89% | -$35.7M |
|
992
Fortrea Holdings
FTRE
$1.82B
| $4.81M | 0.01% |
+119,759
| New | +$4.15M |
|
|
MOR
993
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $4.81M | 0.01% |
264,961
-61,125
| -19% | -$904K |
|
994
Ryan Specialty Holdings
RYAN
$5.59B
| $4.81M | 0.01% |
+86,600
| New | +$4.14M |
|
|
GTACW
995
CALL
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
| $4.79M | 0.01% |
429,791
| – | – |
|
996
Diageo
DEO
$47.3B
| $4.79M | 0.01% |
32,200
+17,460
| +118% | +$2.56M |
|
|
KDKRW
997
CALL
Kodiak AI Warrants
KDKRW
| $4.76M | 0.01% |
450,000
-50,000
| -10% | -$9.62K |
|
998
Consolidated Edison
ED
$41.1B
| $4.76M | 0.01% |
52,400
-9,438
| -15% | -$846K |
|
999
CALL
Snowflake
SNOW
$94.6B
| $4.75M | 0.01% |
+29,500
| New | +$5.72M |
|
|
MRUS
1000
DELISTED
Merus
MRUS
| $4.72M | 0.01% |
+104,892
| New | +$4.25M |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.